Multicentric Castleman's Disease presenting with bilateral panuveitis.

Afonso Murta, Catarina Mota, Bruna Cunha, Nuno Rodrigues Alves, Christopher Saunders, Sofia Pinheiro, Lívio Costa, Rita Anjos
{"title":"Multicentric Castleman's Disease presenting with bilateral panuveitis.","authors":"Afonso Murta, Catarina Mota, Bruna Cunha, Nuno Rodrigues Alves, Christopher Saunders, Sofia Pinheiro, Lívio Costa, Rita Anjos","doi":"10.1097/ICB.0000000000001715","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To report a rare case of Multicentric Castleman's Disease presenting with bilateral panuveitis.</p><p><strong>Methods: </strong>Case report.</p><p><strong>Results: </strong>A 65-years-old caucasian man presented with progressive blurred vision in both eyes for two weeks, along with weight loss, polyarthralgias and reduced muscle strength persisting for about a year. Examination revealed bilateral panuveitis after intraocular lymphoma being initially considered. CT scans showed multiple lymph node enlargements suggestive of lymphoproliferative disorder. Excisional biopsy of an axillary lymph node confirmed the diagnosis of plasmacytic type Castleman's disease. Treatment was started with topical dexamethasone and tropicamide for anterior chamber inflammation, followed by oral prednisolone. After definitive diagnosis, treatment with siltuximab was initiated, which led to significant improvement in panuveitis and systemic symptoms. The patient became off corticosteroids and continued on siltuximab with stable visual acuity and low-grade vitritis.</p><p><strong>Conclusion: </strong>To the best of our knowledge we described the first case in which the diagnosis of Multicentric Castleman's Disease was established through the investigation of bilateral panuveitis, which was successfully managed with corticosteroids and siltuximab.</p>","PeriodicalId":53580,"journal":{"name":"Retinal Cases and Brief Reports","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-01-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Retinal Cases and Brief Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/ICB.0000000000001715","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To report a rare case of Multicentric Castleman's Disease presenting with bilateral panuveitis.

Methods: Case report.

Results: A 65-years-old caucasian man presented with progressive blurred vision in both eyes for two weeks, along with weight loss, polyarthralgias and reduced muscle strength persisting for about a year. Examination revealed bilateral panuveitis after intraocular lymphoma being initially considered. CT scans showed multiple lymph node enlargements suggestive of lymphoproliferative disorder. Excisional biopsy of an axillary lymph node confirmed the diagnosis of plasmacytic type Castleman's disease. Treatment was started with topical dexamethasone and tropicamide for anterior chamber inflammation, followed by oral prednisolone. After definitive diagnosis, treatment with siltuximab was initiated, which led to significant improvement in panuveitis and systemic symptoms. The patient became off corticosteroids and continued on siltuximab with stable visual acuity and low-grade vitritis.

Conclusion: To the best of our knowledge we described the first case in which the diagnosis of Multicentric Castleman's Disease was established through the investigation of bilateral panuveitis, which was successfully managed with corticosteroids and siltuximab.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
多中心Castleman病表现为双侧全葡萄膜炎。
目的:报告一例罕见的以双侧全葡萄膜炎为表现的多中心Castleman病。方法:病例报告。结果:65岁白人男性,双眼进行性视力模糊两周,体重下降,多关节痛和肌肉力量下降持续约一年。检查发现双侧葡萄膜炎后,最初考虑眼内淋巴瘤。CT扫描显示多发淋巴结肿大提示淋巴增生性疾病。腋窝淋巴结的切除活检证实浆细胞型Castleman病的诊断。治疗开始时,外用地塞米松和托品酰胺治疗前房炎症,随后口服强的松龙。确诊后,开始使用西妥昔单抗治疗,导致全葡萄膜炎和全身症状显著改善。患者停用糖皮质激素,继续使用西妥昔单抗,视力稳定,伴有轻度玻璃体炎。结论:据我们所知,我们描述了第一例多中心Castleman病的诊断是通过双侧全葡萄膜炎的调查建立的,并成功地用皮质类固醇和西妥昔单抗治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Retinal Cases and Brief Reports
Retinal Cases and Brief Reports Medicine-Ophthalmology
CiteScore
2.10
自引率
0.00%
发文量
342
期刊最新文献
Drusen Regression Following Macular Hole Surgery: A Case Report. Treatment of vision-threatening branch retinal artery occlusion following coronary angioplasty with surgical displacement of embolus. Punctate Inner Choroidopathy (PIC)-like Reaction in Stage 3 Extensive Macular Atrophy with Pseudodrusen-like Appearance (EMAP). A 19-year-old asymptomatic woman. Multicentric Castleman's Disease presenting with bilateral panuveitis.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1